Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
Fish and Richardson
Teva
Colorcon
Merck
Chubb
Cipla
Medtronic

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019821

« Back to Dashboard

NDA 019821 describes SORIATANE, which is a drug marketed by Stiefel Labs Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the SORIATANE profile page.

The generic ingredient in SORIATANE is acitretin. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acitretin profile page.
Summary for 019821
Tradename:SORIATANE
Applicant:Stiefel Labs Inc
Ingredient:acitretin
Patents:0
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 019821
Ingredient-typeRetinoids
Medical Subject Heading (MeSH) Categories for 019821
Suppliers and Packaging for NDA: 019821
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SORIATANE acitretin CAPSULE;ORAL 019821 NDA Stiefel Laboratories Inc 0145-0090 N 0145-0090-25
SORIATANE acitretin CAPSULE;ORAL 019821 NDA Stiefel Laboratories Inc 0145-0091 N 0145-0091-25

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Oct 28, 1996TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength25MG
Approval Date:Oct 28, 1996TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength17.5MG
Approval Date:Aug 6, 2009TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cipla
US Department of Justice
Johnson and Johnson
Harvard Business School
Baxter
Covington
QuintilesIMS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.